SHL Telemedicine Ltd. Unsponsored ADR (SHLT)
(Delayed Data from NSDQ)
$3.26 USD
+0.02 (0.62%)
Updated Sep 6, 2024 03:13 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for SHL Telemedicine Ltd Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 26 | 19 | 32 | -99,999 | -99,999 |
Receivables | 10 | 10 | 10 | NA | NA |
Notes Receivable | 0 | 0 | 0 | NA | NA |
Inventories | 3 | 4 | 4 | NA | NA |
Other Current Assets | 0 | 0 | 0 | NA | NA |
Total Current Assets | 40 | 32 | 46 | NA | NA |
Net Property & Equipment | 5 | 5 | 4 | NA | NA |
Investments & Advances | 0 | 0 | 0 | NA | NA |
Other Non-Current Assets | 2 | 2 | 0 | NA | NA |
Deferred Charges | 2 | 3 | 4 | NA | NA |
Intangibles | 53 | 54 | 58 | NA | NA |
Deposits & Other Assets | 4 | 4 | 4 | NA | NA |
Total Assets | 113 | 111 | 130 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 2 | 2 | 2 | NA | NA |
Accounts Payable | 4 | 4 | 3 | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | 0 | NA | NA |
Current Portion Capital Leases | 2 | 2 | 2 | NA | NA |
Accrued Expenses | 0 | 0 | 0 | NA | NA |
Income Taxes Payable | 0 | 0 | 1 | NA | NA |
Other Current Liabilities | 9 | 10 | 9 | NA | NA |
Total Current Liabilities | 17 | 18 | 17 | NA | NA |
Mortgages | 0 | 0 | 0 | NA | NA |
Deferred Taxes/Income | 2 | 3 | 3 | NA | NA |
Convertible Debt | 0 | 0 | 0 | NA | NA |
Long-Term Debt | 10 | 13 | 17 | NA | NA |
Non-Current Capital Leases | 5 | 9 | 11 | NA | NA |
Other Non-Current Liabilities | 2 | 9 | 20 | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | NA | NA |
Total Liabilities | 37 | 51 | 69 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | NA | NA |
Common Stock (Par) | 0 | 0 | 0 | NA | NA |
Capital Surplus | 159 | 132 | 127 | NA | NA |
Retained Earnings | -80 | -73 | -73 | NA | NA |
Other Equity | -2 | 0 | 7 | NA | NA |
Treasury Stock | 0 | 0 | 0 | NA | NA |
Total Shareholder's Equity | 76 | 59 | 61 | NA | NA |
Total Liabilities & Shareholder's Equity | 113 | 111 | 130 | NA | NA |
Total Common Equity | 76 | 59 | 61 | 0 | 0 |
Shares Outstanding | 14.60 | 14.60 | NA | NA | NA |
Book Value Per Share | 5.24 | 4.06 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for SHL Telemedicine Ltd Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 26 | -99,999 | 29 |
Receivables | NA | NA | 10 | NA | 11 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | NA | NA | 3 | NA | 4 |
Other Current Assets | NA | NA | 0 | NA | NA |
Total Current Assets | NA | NA | 40 | NA | 44 |
Net Property & Equipment | NA | NA | 5 | NA | 5 |
Investments & Advances | NA | NA | 0 | NA | NA |
Other Non-Current Assets | NA | NA | 2 | NA | 2 |
Deferred Charges | NA | NA | 2 | NA | 2 |
Intangibles | NA | NA | 53 | NA | 53 |
Deposits & Other Assets | NA | NA | 4 | NA | 4 |
Total Assets | NA | NA | 113 | NA | 120 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 2 | NA | 2 |
Accounts Payable | NA | NA | 4 | NA | 4 |
Current Portion Long-Term Debt | NA | NA | 0 | NA | NA |
Current Portion Capital Leases | NA | NA | 2 | NA | 2 |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | NA | NA | 0 | NA | 0 |
Other Current Liabilities | NA | NA | 9 | NA | 8 |
Total Current Liabilities | NA | NA | 17 | NA | 16 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | NA | NA | 2 | NA | 2 |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | NA | NA | 10 | NA | 11 |
Non-Current Capital Leases | NA | NA | 5 | NA | 9 |
Other Non-Current Liabilities | NA | 2 | NA | 2 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | NA | NA | 37 | NA | 40 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | NA | NA | 0 | NA | 0 |
Capital Surplus | NA | NA | 159 | NA | 158 |
Retained Earnings | NA | NA | -80 | NA | -75 |
Other Equity | NA | NA | -2 | NA | -4 |
Treasury Stock | NA | NA | 0 | NA | 0 |
Total Shareholder's Equity | NA | NA | 76 | NA | 80 |
Total Liabilities & Shareholder's Equity | NA | NA | 113 | NA | 120 |
Total Common Equity | 0 | 0 | 76 | 0 | 100,079 |
Shares Outstanding | 14.60 | 14.60 | 14.60 | 14.60 | 14.60 |
Book Value Per Share | 0.00 | 0.00 | 5.24 | 0.00 | 6,854.70 |